Loading...

Home
ETF
ESPR

ESPR

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ESPR News

Esperion Grants Restricted Stock Units to New Employees

4d agoNewsfilter

Esperion Therapeutics Reports Strong 2025 Preliminary Results with $400 Million Revenue

Jan 12 2026NASDAQ.COM

Esperion Reports $156-$160 Million in 2025 Sales, Unveils Vision 2040 Strategy

Jan 12 2026Globenewswire

Esperion's Bempedoic Acid Recognized by ACC as First-Line LDL-C Lowering Therapy

Dec 19 2025Globenewswire

Esperion's Bempedoic Acid Recognized by ACC for LDL-C Lowering in PAD Patients

Dec 19 2025Newsfilter

Esperion Grants 380,000 Stock Options and 435,536 RSUs to New CCO John Harlow

Dec 09 2025Newsfilter

Piper Sandler Upgrades Esperion to Overweight Due to CV Franchise

Nov 25 2025SeekingAlpha

Esperion to Take Part in the 37th Annual Healthcare Conference Hosted by Piper Sandler

Nov 19 2025Newsfilter

HLS, Esperion's Partner, Secures Health Canada Approval for NILEMDO to Reduce LDL Cholesterol

Nov 18 2025NASDAQ.COM

DoorDash Reports Disappointing Q3 Earnings, Alongside elf Beauty, Duolingo, HubSpot, and Other Major Stocks Declining in Thursday's Pre-Market Trading

Nov 06 2025Benzinga

Snap Shares Surge Nearly 20%; Check Out 20 Stocks Making Moves in Premarket Trading

Nov 06 2025Benzinga

Esperion Therapeutics Reports GAAP EPS of -$0.16, Falling Short by $0.08; Revenue of $87.3M Exceeds Expectations by $9.5M

Nov 06 2025SeekingAlpha

ESPR Seeks Diversification Through Rare Liver Disease Candidate, Shares Rise

Oct 17 2025NASDAQ.COM

Esperion Therapeutics (ESPR): Evaluating Valuation Following $75 Million Discounted Stock Sale and Decline in Share Price

Oct 11 2025Yahoo Finance

Major Stock Movers on Wednesday: JOBY, OMI, and Others

Oct 08 2025SeekingAlpha

Esperion's Stock Drops Following $75M Share Offering Announcement

Oct 08 2025SeekingAlpha